Stock of Interest

Posted On: August 9, 2023

Stock Report:  GLAND(NSE) 08 Aug 2023 

Gland Pharma Limited, an Indian pharmaceutical company established in 1978, has its headquarters in India. The company is led by CEO Srinivas Sadu, who assumed the role on April 25, 2019. With a workforce of 4,752 employees as of 2023, Gland Pharma is actively engaged in the pharmaceutical sector, likely involved in the manufacturing and distribution of pharmaceutical products. The company operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd., a Chinese pharmaceutical and healthcare conglomerate. Additionally, Gland Pharma Limited has a subsidiary known as Gland Pharma International Pte. Ltd. As part of a larger organization, Gland Pharma likely contributes to the global pharmaceutical landscape under the umbrella of Fosun Pharma.

#xCalData predicts that # GLAND will continue its bullish phase over the next five days and trend within the range of 1593 to 1824. 

In comparison to the previous month, the price of the stock has experienced an increase of 54.00% indicating a bullish. 

The Stock has doubled Once since 20 Nov 2020 and took an average of 0.6 years to double.   

The stock has not shown seasonality trend in the past. 

Reviewing the returns for the past 2 years for the same week, we see the stock has given Positive returns in 2 years in the past. 

Majority of the technical ratios trend towards Bullish side of the spectrum. Only Trendline Indicates Bearish View. 

Collectively, xCalData suggests the stock would be in Bullish zone for next 5 days. 

#xCalData is an exceptional app available for Android devices that offers unbiased insights into stocks, allowing investors to make informed decisions. With its user-friendly interface and comprehensive features, xCalData provides a valuable resource for anyone interested in the stock market.  Download the app from google play. 

For Actionable Intelligence, subscribe to xCalData app on Android devices: https://tinyurl.com/downloadxCalData